All staff administering this medication must observe and comply with the Structured Administration and Supply Arrangement.
- FLUARIX TETRA is an inactivated and purified split influenza vaccine.
- The antigen composition and strains for the 2024 influenza season corresponds to the following types:
- A/Victoria/4897/2022 (H1N1)pdm09-like strain
- A/Thailand/8/2022 (H3N2)-like strain B
- B/Austria/1359417/2021-like strain
- B/Phuket/3073/2013-like strain
- Annual immunisation against seasonal influenza (for administration to SJWA personnel only)
- Past history of Guillain-Barré syndrome
- FLUARIX TETRA should not be administered to individuals with known hypersensitivity after previous administration of FLUARIX TETRA or influenza vaccines or to any component of the vaccine.
- FLUARIX TETRA can be given to adults aged ≥65 years, however both the adjuvanted (Fluad® Quad) and high dose influenza vaccine (Fluzone High Dose Quadrivalent) are preferentially recommended over standard influenza vaccine.
- Patients must be well on the day of vaccination and provide voluntary consent prior to receiving the vaccination.
- FLUARIX TETRA should under no circumstances be administered intravascularly.
- As with other vaccines, vaccination with FLUARIX TETRA should be postponed in individuals suffering from an acute severe febrile illness.
- Adverse event following immunisation (AEFI) may occur. These AEFI must be reported to WA Department of Health through the Western Australian Vaccine Safety Surveillance (WAVSS) reporting system.
- Pre-filled syringe containing 0.5ml monodose
| kg | ||
| Mode: | ||
| Weight: | ||
| Cefazolin for fractures/prophylaxis |
| Presentation: /mL |
| Calculated dose: in |
- Administer as per the Influenza Vaccination Clinical Skill.
- Mild and short-lasting side effects. These can include but are not limited to:
- Pain
- Redness and swelling at the injection site
- Low grade temperature, and/or
- Muscle aches
- Pre-filled syringe in pack of 1 and 10.
- Colourless slightly opalescent liquid.
- Pharmaceutical form: Suspension for injection.
The vaccine also contains:
- polysorbate 80
- octoxinol 10
- dl-alpha-tocopheryl hydrogen succinate
- sodium chloride
- dibasic sodium phosphate dodecahydrate
- potassium dihydrogen phosphate
- potassium chloride
- magnesium chloride hexahydrate
- water for injections
- ovalbumin (≤0.05 micrograms) (trace)
- formaldehyde (≤5 micrograms) (trace)
- hydrocortisone (trace)
- gentamicin sulphate (trace)
- sodium deoxycholate (trace)
Presentation image
| Settings | |
|---|---|
| Current mode: | |
| Extended Care: | |
| Colour assist: | |
Document Control
Clinical Resources Website
St John Ambulance Western Australia Ltd (ABN 55 028 468 715) (St John WA) operates ambulance and other pre-hospital clinical services. St John WA’s Clinical Resources, including its Clinical Practice Guidelines (Clinical Resources), are intended for use by credentialed St John WA staff and volunteers when providing clinical care to patients for or on behalf of St John WA, within the St John WA Clinical Governance Framework, and only to the extent of the clinician’s authority to practice.
Other users – Terms of Use
The content of the St John WA Clinical Resources is provided for information purposes only and is not intended to serve as health, medical or treatment advice. Any user of this website agrees to be bound by these Terms of Use in their use of the Clinical Resources.
St John WA does not represent or warrant (whether express, implied, statutory, or otherwise) that the content of the Clinical Resources is accurate, reliable, up-to-date, complete or that the information contained is suitable for your needs or for any particular purpose. You are responsible for assessing whether the information is accurate, reliable, up-to-date, authentic, relevant, or complete and where appropriate, seek independent professional advice.
St John WA expressly prohibits use of these Clinical Resources to guide clinical care of patients by organisations external to St John WA, except where these organisations have been directly engaged by St John WA to provide services. Any use of the Clinical Resources, with St John WA approval, must attribute St John WA as the creator of the Clinical Resources and include the copyright notice and (where reasonably practicable) provide a URL/hyperlink to the St John WA Clinical Resources website.
No permission or licence is granted to reproduce, make commercial use of, adapt, modify or create derivative works from these Clinical Resources. For permissions beyond the scope of these Terms of Use, including a commercial licence, please contact medservices@stjohnambulance.com.au
Where links are provided to resources on external websites, St John WA:
- Gives no assurances about the quality, accuracy or relevance of material on any linked site;
- Accepts no legal responsibility regarding the accuracy and reliability of external material; and
- Does not endorse any material, associated organisation, product or service on other sites.
Your use of any external website is governed by the terms of that website, including any authorisation, requirement or licence for use of the material on that website.
To the maximum extent permitted by law, St John WA excludes liability (including liability in negligence) for any direct, special, indirect, incidental, consequential, punitive, exemplary or other loss, cost, damage or expense arising out of, or in connection with, use or reliance on the Clinical Resources (including without limitation any interference with or damage to a user’s computer, device, software or data occurring in connection with such use).
Cookies
Please read this cookie policy carefully before using Clinical Resources from St John WA.
The cookies used on this site are small and completely anonymous pieces of information and are stored on your computer or mobile device. The data that the cookies contain identify your user preferences (such as your preferred text size, scope / skill level preference and Colour Assist mode, among other user settings) so that they can be recalled the next time that you visit a page within Clinical Resources. These cookies are necessary to offer you the best and most efficient possible experience when accessing and navigating through our website and using its features. These cookies do not collect or send analytical information back to St John WA.
Clinical Resources does integrate with Google Analytics and any cookies associated with this service enable us (and third-party services) to collect aggregated data for statistical purposes on how our visitors use this website. These cookies do not contain personal information such as names and email addresses and are used to help us improve your user experience of the website.
If you want to restrict or block the cookies that are set by our website, you can do so through your browser setting. Alternatively, you can visit www.internetcookies.com, which contains comprehensive information on how to do this on a wide variety of browsers and devices. You will find general information about cookies and details on how to delete cookies from your device. If you have any questions about this policy or our use of cookies, please contact us.